MedPath

苏州爱美津制药有限公司

Ownership
-
Established
1997-06-03
Employees
-
Market Cap
-
Website
www.suzhouamerigen.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

NMPA:12

Drug Approvals

Mecobalamin Tablets

Product Name
麦拓
Approval Number
国药准字H20051774
Approval Date
Jul 28, 2020
NMPA

Metoprolol Tartrate Tablets

Product Name
酒石酸美托洛尔片
Approval Number
国药准字H20034091
Approval Date
Jul 28, 2020
NMPA

Metoprolol Tartrate Tablets

Product Name
酒石酸美托洛尔片
Approval Number
国药准字H20058292
Approval Date
Jul 28, 2020
NMPA

Meloxicam Tablets

Product Name
迈洁
Approval Number
国药准字H20020141
Approval Date
Jul 24, 2020
NMPA

Rifampin Isoniazid and Pyrazinamide Tablets

Product Name
维葆
Approval Number
国药准字H20020188
Approval Date
Jul 24, 2020
NMPA

Itopride Hydrochloride Tablets

Product Name
凯亭
Approval Number
国药准字H20030977
Approval Date
Jul 24, 2020
NMPA

Metformin Hydrochloride Tablets

Product Name
盐酸二甲双胍片
Approval Number
国药准字H20033545
Approval Date
Jul 24, 2020
NMPA

Rifampin and Isoniazid Tablets

Product Name
维菲
Approval Number
国药准字H20020189
Approval Date
Jul 24, 2020
NMPA

Meloxicam

Product Name
美洛昔康
Approval Number
国药准字H20020140
Approval Date
Dec 28, 2016
NMPA

Bambuterol Hydrochloride

Product Name
盐酸班布特罗
Approval Number
国药准字H20010404
Approval Date
Sep 28, 2015
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.